We are live on ! Find out more
FAS

Formuepleje A/S Portfolio holdings

AUM $1.28B
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+24.24%
3 Year Est. Return
+75.12%
5 Year Est. Return
+78.91%
10 Year Est. Return
+321.64%
AUM
$740M
AUM Growth
+$8.17M
Cap. Flow
-$26.7M
Cap. Flow %
-3.61%
Top 10 Hldgs %
55.5%
Holding
76
New
4
Increased
23
Reduced
32
Closed
6

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$22.8M
2
WFC icon
Wells Fargo
WFC
+$20.6M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$20.1M
4
SLB icon
SLB Ltd
SLB
+$9.85M
5
SRCL
Stericycle Inc
SRCL
+$9.61M

Top Sells

Rank Stock Value
1
CME icon
CME Group
CME
+$22.3M
2
PG icon
Procter & Gamble
PG
+$21.6M
3
PH icon
Parker-Hannifin
PH
+$15.2M
4
AXP icon
American Express
AXP
+$14.8M
5
BID
Sotheby's
BID
+$12.7M

Sector Composition

Rank Sector Weight
1 Financials 29.66%
2 Healthcare 21.3%
3 Technology 11.14%
4 Consumer Discretionary 10.04%
5 Industrials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.75T
$61.1M 8.26%
1,060,642
-26,200
-2% -$1.48M
SPGI icon
2
S&P Global
SPGI
$128B
$58.6M 7.92%
462,815
-64,300
-12% -$7.72M
UNH icon
3
UnitedHealth
UNH
$355B
$56.5M 7.63%
403,453
-76,400
-16% -$10.7M
SCI icon
4
Service Corp International
SCI
$11.4B
$41.2M 5.56%
1,551,250
+198,700
+15% +$5.38M
DOV icon
5
Dover
DOV
$27.2B
$39M 5.27%
655,249
+10,895
+2% +$630K
GILD icon
6
Gilead Sciences
GILD
$185B
$32M 4.33%
405,079
+55,100
+16% +$4.48M
MCO icon
7
Moody's
MCO
$88.2B
$31.7M 4.29%
292,870
-8,200
-3% -$862K
ELV icon
8
Elevance Health
ELV
$86.6B
$31.5M 4.25%
251,248
+176,500
+236% +$22.8M
V icon
9
Visa
V
$709B
$31.1M 4.2%
375,760
+25,100
+7% +$2.01M
SLB icon
10
SLB Ltd
SLB
$81.6B
$28.1M 3.79%
356,975
+124,100
+53% +$9.85M
PG icon
11
Procter & Gamble
PG
$333B
$25.9M 3.49%
288,090
-249,000
-46% -$21.6M
OMC icon
12
Omnicom Group
OMC
$24.1B
$23.7M 3.21%
279,388
-15,700
-5% -$1.32M
AXP icon
13
American Express
AXP
$226B
$23.2M 3.14%
362,727
-230,700
-39% -$14.8M
SRCL
14
DELISTED
Stericycle Inc
SRCL
$22.8M 3.08%
283,960
+106,300
+60% +$9.61M
NKE icon
15
Nike
NKE
$57B
$19.9M 2.69%
377,658
+97,300
+35% +$5.49M
BIIB icon
16
Biogen
BIIB
$32.7B
$19.7M 2.66%
62,800
-4,700
-7% -$1.39M
GS icon
17
Goldman Sachs
GS
$303B
$19.2M 2.6%
119,230
-7,900
-6% -$1.28M
WFC icon
18
Wells Fargo
WFC
$257B
$19.1M 2.58%
+431,300
New +$20.6M
TEVA icon
19
Teva Pharmaceuticals
TEVA
$43.8B
$17.7M 2.39%
+384,700
New +$20.1M
GOOG icon
20
Alphabet (Google) Class C
GOOG
$4.13T
$17.6M 2.38%
454,000
-24,000
-5% -$911K
C icon
21
Citigroup
C
$223B
$16.7M 2.25%
352,790
+66,600
+23% +$3.03M
PX
22
DELISTED
Praxair Inc
PX
$15.9M 2.15%
131,470
-38,300
-23% -$4.53M
CSCO icon
23
Cisco
CSCO
$442B
$12.6M 1.71%
398,023
-4,900
-1% -$151K
BLK icon
24
Blackrock
BLK
$181B
$12.5M 1.69%
34,457
-300
-0.9% -$109K
ENIA
25
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$9.48M 1.28%
1,157,051
-107,100
-8% -$920K

Similar funds

Formuepleje A/S's Q3 2016 Portfolio in Review

As of Q3 2016, Formuepleje A/S held 76 positions worth $740M, up 1.1% from $732M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Formuepleje A/S withdrew a net $26.7M in Q3 2016, closing 6 positions and reducing 32 holdings. Its most notable exit was Parker-Hannifin, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Formuepleje A/S opened a new position in Wells Fargo worth $19.1M.

  • Formuepleje A/S's largest Q3 2016 buy was Wells Fargo: 431,300 shares worth $19.1M.
  • Formuepleje A/S added most to Elevance Health in Q3 2016, an estimated $22.8M increase.
  • Formuepleje A/S's biggest Q3 2016 reduction was CME Group, cutting an estimated $22.3M.
  • Formuepleje A/S fully exited Parker-Hannifin in Q3 2016, selling an estimated $15.2M.
  • Formuepleje A/S's ten largest holdings make up 55% of its $740M portfolio in Q3 2016.
  • Formuepleje A/S opened 4 new positions and closed 6 in Q3 2016.
  • Formuepleje A/S's portfolio value rose 1.1% quarter-over-quarter to $740M.

Based on Formuepleje A/S's 13F filing for Q3 2016, filed 27 Aug 2026.